2 active trials 1 recruiting 3 disease areas 1 changes in 30 days
| Phase 2 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06483282 | A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant… | Small Cell Lung Cancer Limited Stage | Recruiting | 2026-09-11 |
| NCT06530719 | A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated… | Lung Neoplasms | Not Yet Recruiting | 2024-07-31 |
Lung Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (1) · Small Cell Lung Cancer (1)